Association of ultra-sensitive ctDNA assay to identify actionable variants and response to immune checkpoint inhibitor (ICI) therapy in metastatic melanoma

被引：0
|
作者：
Gebhardt, Christoffer
Keller, Laura
Heidrich, Isabel
Koett, Julian
Geidel, Glenn
Abbott, Charles
Boyle, Sean Michael
Pugh, Jason
Chen, Richard
Simon, Ronald
Schneider, Stefan W.
Pantel, Klaus
机构：
[1] Univ Med Ctr Hamburg Eppendorf UKE, Skin Canc Ctr, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf UKE, Inst Tumor Biol, Hamburg, Germany
[3] Personalis Inc, Menlo Pk, CA USA
[4] Univ Med Ctr Hamburg Eppendorf UKE, Inst Pathol, Hamburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf UKE, Dept Dermatol, Hamburg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9562
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Ultra-sensitive ctDNA detection predicts response to immune checkpoint inhibition in advanced melanoma patients
    Gebhardt, Christoffer
    Keller, Laura
    Heidrich, Isabel
    Koett, Julian
    Geidel, Glenn
    Smit, Daniel J.
    Simon, Ronald
    Schneider, Stefan W.
    Pugh, Jason
    Abbott, Charles W.
    Boyle, Sean
    Chen, Richard O.
    Pantel, Klaus
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Ultra-sensitive tumor-informed ctDNA assay predicts survival in advanced melanoma patients treated with immune checkpoint inhibition
    Keller, Laura
    Heidrich, Isabel
    Kott, Julian
    Abbott, Charles W.
    Boyle, Sean
    Pugh, Jason
    Chen, Richard O.
    Geidel, Glen
    Ronald, Simon
    Schneider, Stephan W.
    Gebhardt, Christoffer
    Pantel, Klaus
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Ultra-sensitive tumor-informed ctDNA assay predicts survival in advanced melanoma patients treated with ICI treatment
    Pan, H.
    Keller, L.
    Heidrich, I.
    Kott, J.
    Abbott, C. W.
    Boyle, S.
    Pugh, J.
    Chen, R. O.
    Geidel, G.
    Ronald, S.
    Schneider, S.
    Gebhardt, C.
    Pantel, K.
    ANNALS OF ONCOLOGY, 2024, 35 : S1373 - S1373
  • [4] Development and application of an ultra-sensitive ctDNA mutation profiling assay in monitoring therapy response and drug resistance.
    Zhang, Tom
    Singh, Harshabad
    Tan, Lu
    Wang, Xiaohong
    Zhao, Zhixin
    Zhou, Kemin
    Luo, Shujun
    Jia, Shidong
    Du, Pan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 264 - 264
  • [5] The Symptom Experience of Patients with Advanced Melanoma Undergoing Immune Checkpoint Inhibitor (ICI) Therapy
    Jackson-Carroll, Natalie
    Johnson, Constance
    Tawbi, Hussein
    Wang, Xin Shelley
    Whisenant, Meagan
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (01)
  • [6] Association of dermoscopic signs of regression in melanocytic lesions with immune checkpoint inhibitor response in metastatic melanoma patients
    Belkaid, Samy
    Clerc, Marion
    Amini-Adle, Mona
    Maucort-Boulch, Delphine
    Dalle, Stephane
    Thomas, Luc
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025,
  • [7] Resistance to immune checkpoint inhibitor (ICI) therapy in metastatic melanoma is revealed by deep circulating tumor DNA tracking in concert with tumor immune profiling
    Abbott, Charles W.
    Keller, Laura
    Heidrich, Isabel
    Kott, Julian
    Geidel, Glenn
    Smit, Daniel J.
    Simon, Ronald
    Schneider, Stefan
    Pugh, Jason
    Boyle, Sean M.
    Chen, Richard O.
    Pantel, Klaus
    Gebhardt, Christoffer
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Ultra-sensitive ctDNA dynamics to capture therapy response in pembrolizumab-treated gastroesophageal cancer
    Nixon, Andrew B.
    Navarro, Fabio
    Zhou, Katherine I.
    Abbott, Charles
    Howard, Lauren
    Brady, John C.
    Liu, Yingmiao
    Jia, Jingquan
    Niedzwiecki, Donna
    Chen, Richard
    Strickler, John H.
    Boyle, Sean Michael
    Uronis, Hope Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Outcomes of melanoma patients with brain metastases receiving immune checkpoint inhibitor (ICI) therapy.
    Ardeshir-Larijani, Fatemeh
    Nelson, Ariel Ann
    Martin, Petra
    Mendiratta, Prateek
    Sloan, Andrew E.
    Choi, Serah
    Mansur, David B.
    Hoimes, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
    Auslander, Noam
    Zhang, Gao
    Lee, Joo Sang
    Frederick, Dennie T.
    Miao, Benchun
    Moll, Tabea
    Tian, Tian
    Wei, Zhi
    Madan, Sanna
    Sullivan, Ryan J.
    Boland, Genevieve
    Flaherty, Keith
    Herlyn, Meenhard
    Ruppin, Eytan
    NATURE MEDICINE, 2018, 24 (10) : 1545 - +
12345